Sugemalimab is an experimental monoclonal antibody intended for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) in combination...
7 KB (398 words) - 05:33, 13 June 2024
pustular psoriasis (GPP) Stamulumab mab human myostatin muscular dystrophy Sugemalimab mab human PD-1 non-small-cell lung cancer Sulesomab LeukoScan Fab' mouse...
135 KB (4,054 words) - 22:35, 2 July 2024
Ramucirumab Retifanlimab Sabatolimab Sacituzumab govitecan Serplulimab Sugemalimab Tafasitamab Talquetamab Tarlatamab Teclistamab Tislelizumab Tisotumab...
12 KB (760 words) - 05:52, 10 June 2024
Ramucirumab Retifanlimab Sabatolimab Sacituzumab govitecan Serplulimab Sugemalimab Tafasitamab Talquetamab Tarlatamab Teclistamab Tislelizumab Tisotumab...
12 KB (758 words) - 23:46, 14 March 2024
L01FF08 Prolgolimab L01FF09 Tislelizumab L01FF10 Retifanlimab L01FF11 Sugemalimab L01FF12 Serplulimab L01FF13 Toripalimab L01FG01 Bevacizumab L01FG02 Ramucirumab...
12 KB (877 words) - 15:36, 25 January 2024
sufosfamide (INN) sufotidine (INN) sufugolix (INN) sugammadex (INN) sugemalimab (INN) Sular sulazepam (INN) sulazuril (INN) sulbactam (INN) sulbenicillin...
9 KB (419 words) - 03:53, 1 June 2024
Pritumumab§ Radretumab§ Ramucirumab Rilotumumab† Robatumumab§ Seribantumab§ Sugemalimab Tarextumab§ Tisotumab vedotin Teprotumumab† Tovetumab§ Vantictumab§ Votumumab§...
3 KB (129 words) - 01:04, 19 July 2023
Pritumumab§ Radretumab§ Ramucirumab Rilotumumab† Robatumumab§ Seribantumab§ Sugemalimab Tarextumab§ Tisotumab vedotin Teprotumumab† Tovetumab§ Vantictumab§ Votumumab§...
4 KB (241 words) - 11:41, 22 April 2022
Pritumumab§ Radretumab§ Ramucirumab Rilotumumab† Robatumumab§ Seribantumab§ Sugemalimab Tarextumab§ Tisotumab vedotin Teprotumumab† Tovetumab§ Vantictumab§ Votumumab§...
5 KB (368 words) - 22:00, 19 October 2020